|
Β |
(11 intermediate revisions by 3 users not shown) |
Line 1: |
Line 1: |
| __TOC__ | | __TOC__ |
| == Picked up - reading and discussion ==
| |
|
| |
| === As we go ===
| |
|
| |
| * 2017-07-31 [https://www.nature.com/polopoly_fs/1.22366!/menu/main/topColumns/topLeftColumn/pdf/547381a.pdf Don't run biomedical science as a business]
| |
|
| |
| * 2017-07-19 Article not only about the shipping of frozen PBMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010910/ [[User:Velikab|Velikab]] ([[User talk:Velikab|talk]])
| |
|
| |
| * 2017-07-11 A very brief comparison of '''O2k vs. Seahorse''':Β Β [[Li 2017 Methodist Debakey Cardiovasc J]]
| |
| ::::::: ''The Oroboros high-resolution respirometer ... can perform multiple injections sequentially for substrates and chemicals. This makes the Oroboros more flexible for comparison purposes.'' >> [[O2k-Feedback]]
| |
|
| |
| * 2017-06-19 [[Gdynia_2016_Nat Commun]] - Malic enzyme; cancer
| |
|
| |
| * 2017-06-08 '''Patent of Q-electrode (1988)''': Dr P.R. Rich, Glynn Res. Ph., Bodmin; European Patent no.85900699.1 [[User:Hungerm|Hungerm]] ([[User talk:Hungerm|talk]]) 10:18, 21 June 2017 (CEST)
| |
|
| |
| * 2017-06-08 ''' Pre-print publication: Mitochondria are physiologically maintained at close to 50 Β°C [[Chretien_2017_bioRxiv |Β»Bioblast linkΒ«]]
| |
|
| |
| * 2017-06-07 '''Important new paper for pfi users''' - [[Meinild 2017 Acta Physiol (Oxf)]]: Exercise training increases skeletal muscle mitochondrial volume density by enlargement of existing mitochondria and not de novo biogenesis.
| |
| ::::* (i) O2k-Network lab; (ii) MitoFit news.
| |
|
| |
| * 2017-05-30 '''Quote of the day''': ".. oligomycin (complex V inhibitor) determines the amount of ATP production is linked to respiration, FCCP (mitochondrial uncoupler) enables measurement of maximal respiratory capacity, while a combination of rotenone (complex I inhibitor) and antimycin A (complex III inhibitor) determines the reserved respiratory capacity." .. and more: "The mitochondrial network is a major site of ATP production through the coupled integration of the electron transport chain (ETC) with oxidative phosphorylation." - Trotta et al (2017) Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition. JBC Papers in Press. Published on May 25, 2017 as Manuscript M117.786442.
| |
| :::: What is ''reserved respiratory capacity''?
| |
|
| |
| * 2017-05-22: [[Komlodi 2017 Neuropharmacology]]
| |
|
| |
| === Various ===
| |
| ::::* [https://www.ncbi.nlm.nih.gov/pubmed/21664270 The rate of oxygen utilization by cells - interesting review beyond ascorbate topic]
| |
| ::::* [http://time.com/4475628/the-new-science-of-exercise/ The new science of exercise]
| |
| ::::* [http://collections.plos.org/s/meta-research?utm_source=dfp&utm_medium=banner&utm_campaign=col-1604-metares Meta-research: Evaluation and improvement of research methods and practices]
| |
|
| |
| === Warburg effect ===
| |
| ::::* Warburg O (1956) On the origin of cancer cells. Science 123:309-14.
| |
| ::::* Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-70.
| |
| ::::* Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-33.
| |
| ::::* Kim JW, Dang CV (2006) Cancerβs molecular sweet tooth and the Warburg effect. Cancer Res 66:8927-30.
| |
| ::::* Review: http://online.liebertpub.com/doi/full/10.1089/ars.2016.6750
| |
| ::::* Review: http://onlinelibrary.wiley.com/doi/10.1111/febs.13402/full
| |
|
| |
|
| |
| == To our editors == | | == To our editors == |
| :::* [[OROBOROS Mitochondrial Research Laboratory]] was moved to [[Oroboros MitoFit Laboratory]] | | :::* [[OROBOROS Mitochondrial Research Laboratory]] was moved to [[Oroboros MitoFit Laboratory]], which was moved to [[Oroboros Laboratory]] |
| :::: >> Please check redirects from [[OROBOROS Mitochondrial Research Laboratory]] | | :::: >> Please check redirects from [[OROBOROS Mitochondrial Research Laboratory]] |
|
| |
|
| :::* [[OROBOROS MitoLab: visiting scientists]] was moved to [[roboros MitoFit lab: visiting scientists]] | | :::* [[OROBOROS MitoLab: visiting scientists]] was moved to [[Oroboros Laboratories: visiting scientists]] |
| :::: >> Please check redirects from [[OROBOROS MitoLab: visiting scientists]] | | :::: >> Please check redirects from [[OROBOROS MitoLab: visiting scientists]] |
|
| |
|
| :::* Rationale: The 'MitoFit Centre of Excellence' or the 'MitoFit Core Facility' will be comprise of the Oroboros MitoFit Laboratory and the DSL MitoFit Facility. | | :::* Rationale: The 'MitoFit Centre of Excellence' or 'MitoFit Core Facility' comprises the Oroboros MitoFit Laboratory and the DSL MitoFit Facility. |
| | :::* Updated: The Oroboros Laboratories are the Oroboros O2k-Laboratory and the DSL-Oroboros Research Lab. |
|
| |
|
| | [[Image:BB-Bioblast.jpg|left|40px|link=Bioblast:About|Bioblast wiki]] |
|
| |
|
| [[Image:BB-Bioblast.jpg|left|40px|link=Bioblast:About|Bioblast wiki]]
| |
| == Popular Bioblast page == | | == Popular Bioblast page == |
| ::: [[Oroboros MitoFit Laboratory]] has been accessed more than Β | | ::: [[Oroboros Laboratory]] has been accessed more than Β |
| ::::*Β 5,000 times (2017-07-05) | | ::::*Β 5,000 times (2017-07-05) |